Research Isn’t Abstract Science But a Pathway to Answers, Treatments, and Hope – ASH
American Society of Hematology shared a post on LinkedIn:
“On Rare Disease Day, let’s remember that research isn’t abstract science but a pathway to answers, treatments, and hope.
For people living with rare blood disorders, every new study, discovery, and clinical trial brings us closer to better diagnostics, safer therapies, and improved quality of life.
The ASH Research Awards Fund supports innovative research that can transform care for rare blood diseases—from early-stage ideas to breakthrough treatments.
When you give, you’re directly fueling the work that patients and families are counting on.
Your support helps to:
- Advance promising research in rare blood disorders
- Accelerate the development of new treatment options
- Bring hope to patients and families worldwide
Together, we can turn rare disease research into real-world impact for the people who need it most.”
Other posts about American Society of Hematology on Hemostasis Today.
-
Jul 28, 2026, 14:40Marilena Vrana: Join the Conversation at Plasma Protein Forum 2026
-
Jul 28, 2026, 14:24Jon Wright: Pushing the Boundaries of Hemophilia Care
-
Jul 28, 2026, 14:11Improving Care for People with Bleeding Disorders Through Teamwork – WFH
-
Jul 28, 2026, 14:10Blessing Oluwasanya: When Heavy Periods Are More Than Just an Inconvenience
-
Jul 28, 2026, 13:46Manal Rayyan: Efanesoctocog Alfa Shows Excellent Real-World Performance
-
Jul 28, 2026, 13:22Raelene Kambli: Advocating for Safer Blood Access
-
Jul 28, 2026, 13:07Connie Montgomery: Conversations That Change Hemophilia Care
-
Jul 28, 2026, 09:06Payal Desai: Highlights from the NASCC 2026 Sickle Cell Workshop
-
Jul 28, 2026, 08:43Flora Peyvandi։ Acquired Hemophilia A – An Illustrated Review Based on French Guidelines